(Q42199418)

English

Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

scientific article published on October 1989

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin) (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

1 reference

based on heuristic

inferred from title

author name string

B H Stricker

1

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

J W Van den Broek

2

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

J Keuning

3

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

W Eberhardt

4

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

H G Houben

5

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

M Johnson

6

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

A P Blok

7

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

publication date

1 October 1989

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

1576-1580

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Flucloxacillin-induced cholestatic liver damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pitfall in diagnosis of viral hepatitis on haemodialysis unit

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloxacillin-induced cholestatic jaundice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholestatic jaundice due to derivatives of oxacillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flucloxacillin-associated liver damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ticarcillin-clavulanic acid therapy in severe infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Cholestatic hepatitis caused by a combination of amoxicillin and clavulanic acid (Augmentin)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged severe cholestasis induced by oxacillin derivatives. A report on two cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combination of amoxicillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxicillin-resistant haemophilus influenzae.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of macrophage inhibition factor and mast-cell degranulation tests for diagnosis of cloxacillin-induced cholestasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholestatic hepatitis after dicloxacillin-sodium therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2791808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01537113

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42199418&oldid=2205113515"